Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule ...

The FDA granted breakthrough therapy status to sacituzumab tirumotecan in EGFR-mutated advanced non–small cell lung cancer.

APL researchers used artificial intelligence and two APL-patented imaging technologies to improve the accuracy and efficiency ...

When Julie Durbin was undergoing cancer treatment, she was always cold. She would bring a cardigan, a sweater that opens in ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal ...

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...

A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but ...

"The platform's key advantage lies in its ability to encapsulate the antibody within the NanoGel during circulation and ensure its controlled release in the bone metastatic niche ... therapy's ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

A recent study led by Lund University in Sweden has found that some patients with aggressive breast cancer can be helped by a ...

Flatiron Health today announced their planned presence at this year’s San Antonio Breast Cancer Symposium (SABCS), including four accepted abstracts for poster presentation and a Flatiron ...

Advances in screenings, genetic testing, more awareness among reasons why doctors are finding cancer in younger patients.